Narcostart Stungulyf, lausn 1 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

narcostart stungulyf, lausn 1 mg/ml

le vet b.v.* - medetomidinum hýdróklóríð - stungulyf, lausn - 1 mg/ml

Lamzede Evrópusambandið - íslenska - EMA (European Medicines Agency)

lamzede

chiesi farmaceutici s.p.a. - velmanase alfa - alfa-mannosidosis - Önnur meltingarvegi og efnaskipti vörur, - meðferð ekki taugakerfi í sjúklinga með vægt til í meðallagi alfa-mannosidosis.

Striverdi Respimat (Infortispir Respimat) Innöndunarlausn 2,5 míkróg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

striverdi respimat (infortispir respimat) innöndunarlausn 2,5 míkróg

boehringer ingelheim international gmbh* - olodaterolum hýdróklóríð - innöndunarlausn - 2,5 míkróg

Losartankalium/hydrochlorthiazid Krka Filmuhúðuð tafla 100 mg/12,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

losartankalium/hydrochlorthiazid krka filmuhúðuð tafla 100 mg/12,5 mg

krka sverige ab - losartanum kalíum; hydrochlorothiazide - filmuhúðuð tafla - 100 mg/12,5 mg

Darazíð Tafla 20 mg/12,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

darazíð tafla 20 mg/12,5 mg

actavis group ptc ehf. - enalaprilum maleat; hydrochlorothiazidum inn - tafla - 20 mg/12,5 mg

Losartankalium/hydrochlorthiazid Krka Filmuhúðuð tafla 100 mg/25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

losartankalium/hydrochlorthiazid krka filmuhúðuð tafla 100 mg/25 mg

krka sverige ab - losartanum kalíum; hydrochlorothiazide - filmuhúðuð tafla - 100 mg/25 mg

Losartankalium/hydrochlorthiazid Krka Filmuhúðuð tafla 50 mg/12,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

losartankalium/hydrochlorthiazid krka filmuhúðuð tafla 50 mg/12,5 mg

krka sverige ab - losartanum kalíum; hydrochlorothiazide - filmuhúðuð tafla - 50 mg/12,5 mg

Spiolto Respimat Innöndunarlausn 2,5/2,5 míkróg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

spiolto respimat innöndunarlausn 2,5/2,5 míkróg

boehringer ingelheim international gmbh* - tiotropii bromidum inn; olodaterolum hýdróklóríð - innöndunarlausn - 2,5/2,5 míkróg

Tivicay Evrópusambandið - íslenska - EMA (European Medicines Agency)

tivicay

viiv healthcare bv - dolutegravír - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.